Know what you really own

Unwrap both →

Fund comparison · from official SEC filings

GNOM vs IBB: how much do they overlap?

Global X Genomics & Biotechnology ETF and iShares Biotechnology ETF

Fund A

vs

Fund B

Holdings overlap

16%

of assets, by weight

Shared positions

35

of 51 / 253 holdings

GNOM expense ratio

0.50%

net, per year

IBB expense ratio

0.44%

net, per year

Shared holdings

Company

GNOM

IBB

V

VRTXVERTEX PHARMACEUTICALS INC

3.84%

6.77%

G

GILDGILEAD SCIENCES INC

1.90%

6.64%

I

ILMNILLUMINA INC

4.68%

1.24%

N

NTRANATERA INC

4.03%

1.87%

B

BMRNBIOMARIN PHARMACEUTICAL INC

3.97%

0.90%

A

ARWRARROWHEAD PHARMACEUTICALS IN

3.95%

0.39%

L

LEGNLEGEND BIOTECH CORP-ADR

3.93%

0.36%

P

PRAXPRAXIS PRECISION MEDICINES I

3.89%

0.09%

T

TWSTTWIST BIOSCIENCE CORP

3.85%

0.14%

C

CRSPCRISPR THERAPEUTICS AG

3.74%

0.49%

V

VCYTVERACYTE INC

3.53%

0.23%

B

BNTXBIONTECH SE-ADR

3.31%

0.55%

T

TECHBIO-TECHNE CORP

3.31%

0.75%

M

MRNAMODERNA INC

3.18%

0.78%

T

TXG10X GENOMICS INC-CLASS A

3.14%

0.11%

B

BEAMBEAM THERAPEUTICS INC

3.00%

0.19%

R

RAREULTRAGENYX PHARMACEUTICAL IN

2.19%

0.24%

S

SRPTSAREPTA THERAPEUTICS INC

1.75%

0.16%

Q

QUREUNIQURE NV

1.55%

0.25%

N

NTLAINTELLIA THERAPEUTICS INC

1.55%

0.15%

S

STOKSTOKE THERAPEUTICS INC

1.41%

0.09%

V

VIRVIR BIOTECHNOLOGY INC

1.08%

0.04%

C

CDNACAREDX INC

1.02%

0.06%

W

WVEWAVE LIFE SCIENCES LTD

1.00%

0.08%

P

PSNLPERSONALIS INC

0.76%

0.03%

Only in GNOM

G

GHGUARDANT HEALTH INC

5.43%

Q

QGENQIAGEN N.V.

3.43%

?

—BNYREPOS

2.96%

L

LLYELI LILLY & CO

2.25%

C

CAICARIS LIFE SCIENCES INC

1.97%

G

GNNSFGENSCRIPT BIOTECH CORP

1.94%

B

BLLNBILLIONTOONE INC CL A

1.92%

A

AZNASTRAZENECA PLC

1.78%

W

WGSGENEDX HOLDINGS CORP

1.31%

D

DHRDANAHER CORP

1.14%

B

BMYBRISTOL-MYERS SQUIBB CO

1.12%

B

BNTCBENITEC BIOPHARMA INC

0.37%

A

AAGILENT TECHNOLOGIES INC

0.37%

M

MLABMESA LABORATORIES INC

0.28%

C

CRBUCARIBOU BIOSCIENCES INC

0.28%

D

DGXQUEST DIAGNOSTICS INC

0.27%

Only in IBB

B

BISXXBCF INSTITUTIONAL-SL AGNCY

11.65%

A

AMGNAMGEN INC

6.63%

R

REGNREGENERON PHARMACEUTICALS

5.03%

A

ALNYALNYLAM PHARMACEUTICALS INC

5.02%

I

IQVIQVIA HOLDINGS INC

2.81%

A

ARGXARGENX SE - ADR

2.78%

I

INSMINSMED INC

2.61%

M

MTDMETTLER-TOLEDO INTERNATIONAL

2.20%

O

ONCBEONE MEDICINES LTD-ADR

1.86%

B

BIIBBIOGEN INC

1.80%

U

UTHRUNITED THERAPEUTICS CORP

1.61%

W

WATWATERS CORP

1.56%

I

INCYINCYTE CORP

1.43%

G

GMABGENMAB A/S -SP ADR

1.22%

N

NBIXNEUROCRINE BIOSCIENCES INC

1.19%

M

MEDPMEDPACE HOLDINGS INC

1.02%

E

EXELEXELIXIS INC

0.94%

I

IONSIONIS PHARMACEUTICALS INC

0.91%

M

MDGLMADRIGAL PHARMACEUTICALS INC

0.81%

A

ASNDASCENDIS PHARMA A/S

0.74%

H

HALOHALOZYME THERAPEUTICS INC

0.74%

B

BBIOBRIDGEBIO PHARMA INC

0.74%

T

TEMTEMPUS AI INC-CL A

0.68%

C

CRLCHARLES RIVER LABORATORIES

0.67%

R

RVMDREVOLUTION MEDICINES INC

0.66%

Hold GNOM and IBB together? See your combined true holdings, overlap, and blended fees — free, no signup.

Unwrap your portfolio →

Other comparisons you might like

IBB vs IBBQInvesco Nasdaq Biotechnology ETF

IBB vs BIBProShares Ultra Nasdaq Biotechnology

IBB vs FHLCFidelity MSCI Health Care Index ETF

IBB vs VHTVANGUARD HEALTH CARE INDEX FUND

IBB vs IWMiShares Russell 2000 ETF

GNOM vs IBBQInvesco Nasdaq Biotechnology ETF

Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.